Glibenclamide 5.00 mg + Pioglitazone 15.00 mg + Metformin Hydrochloride 500.00 mg

GLUCOMUST PM is a fixed-dose combination medication that contains Pioglitazone, Metformin Hydrochloride, and Glibenclamide. Pioglitazone belongs to a class of medications called thiazolidinediones and helps lower blood glucose levels. Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production. Glibenclamide is a sulfonylurea that stimulates insulin release from the pancreas. This combination medicine is indicated for the treatment of type 2 diabetes mellitus to achieve optimal glycemic control. It works by improving insulin action, reducing insulin resistance, and promoting glucose utilization.

Take GLUCOMUST PM orally, as directed by your doctor. It is usually taken with meals to reduce the risk of gastrointestinal side effects. The dosage and frequency will be determined by your doctor based on your individual needs and response to treatment.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.